{"count": 2, "results": [{"_id": "35366264", "pmid": 35366264, "pmcid": "PMC8830455", "title": "The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer's Disease", "journal": "Pathophysiology", "authors": ["Thomas J", "Smith H", "Smith CA", "Coward L", "Gorman G", "De Luca M", "Jumbo-Lucioni P"], "date": "2021-06-18T00:00:00Z", "doi": "10.3390/pathophysiology28020020", "meta_date_publication": "2021 Jun 18", "meta_volume": "28", "meta_issue": "2", "meta_pages": "307-319", "score": 50297.258, "text_hl": "Whether @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ intervention is successful at ameliorating @<m>DISEASE_Memory_Disorders</m> @DISEASE_MESH:D008569 @@@memory deficits@@@ in older @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@AD@@@ flies remain to be determined. ", "citations": {"NLM": "Thomas J, Smith H, Smith CA, Coward L, Gorman G, De Luca M, Jumbo-Lucioni P. The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer's Disease Pathophysiology. 2021 Jun 18;28(2):307-319. PMID: 35366264", "BibTeX": "@article{35366264, title={The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer's Disease}, author={Thomas J and Smith H and Smith CA and Coward L and Gorman G and De Luca M and Jumbo-Lucioni P}, journal={Pathophysiology}, volume={28}, number={2}, pages={307-319}}"}}, {"_id": "19922631", "pmid": 19922631, "pmcid": "PMC2784465", "title": "The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition", "journal": "BMC Geriatr", "authors": ["Hajjar I", "Hart M", "Milberg W", "Novak V", "Lipsitz L"], "date": "2009-11-18T00:00:00Z", "doi": "10.1186/1471-2318-9-48", "meta_date_publication": "2009 Nov 18", "meta_volume": "9", "meta_issue": "", "meta_pages": "48", "score": 50037.406, "text_hl": "Our objective is to conduct a double-blind randomized controlled clinical trial, the antihypertensives and vascular, endothelial, and cognitive function (AVEC), to compare 1 year treatment of 3 antihypertensives (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@, or @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@) in their effect on memory and executive function, cerebral blood flow, and central endothelial function of seniors with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and early objective evidence of executive or @<m>DISEASE_Memory_Disorders</m> @DISEASE_MESH:D008569 @@@memory impairments@@@.", "citations": {"NLM": "Hajjar I, Hart M, Milberg W, Novak V, Lipsitz L. The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition BMC Geriatr. 2009 Nov 18;9():48. PMID: 19922631", "BibTeX": "@article{19922631, title={The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition}, author={Hajjar I and Hart M and Milberg W and Novak V and Lipsitz L}, journal={BMC Geriatr}, volume={9}, pages={48}}"}}]}